相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Functional Roles for C5a and C5aR but Not C5L2 in the Pathogenesis of Human and Experimental Cerebral Malaria
Hani Kim et al.
INFECTION AND IMMUNITY (2014)
Akt-Dependent Enhanced Migratory Capacity of Th17 Cells from Children with Lupus Nephritis
Sudhir Kshirsagar et al.
JOURNAL OF IMMUNOLOGY (2014)
Alterations in Tight Junction Protein and IgG Permeability Accompany Leukocyte Extravasation Across the Choroid Plexus During Neuroinflammation
Bandana Shrestha et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2014)
Essential Role of Program Death 1-Ligand 1 in Regulatory T-Cell-Afforded Protection Against Blood-Brain Barrier Damage After Stroke
Peiying Li et al.
STROKE (2014)
Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus
Shunsei Hirohata et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Blood-brain barrier structure and function and the challenges for CNS drug delivery
N. Joan Abbott
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization
Mike C. L. Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Theranostic quantum dots for crossing blood brain barrier in vitro and providing therapy of HIV-associated encephalopathy
Gaixia Xu et al.
FRONTIERS IN PHARMACOLOGY (2013)
Expression of Tight Junction and Drug Efflux Transporter Proteins in an in vitro Model of Human Blood–Brain Barrier
Chiara Cioni et al.
Frontiers in Psychiatry (2012)
Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus
B. Diamond et al.
JOURNAL OF INTERNAL MEDICINE (2011)
C5a/CD88 signaling alters blood-brain barrier integrity in lupus through nuclear factor-κB
Alexander Jacob et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Assessments of tight junction proteins occludin, claudin 5 and scaffold proteins ZO1 and ZO2 in endothelial cells of the rat blood-brain barrier: Cellular responses to neurotoxicants malathion and lead acetate
Pergentino Balbuena et al.
NEUROTOXICOLOGY (2011)
Zonula Occludens-1 alterations and enhanced intestinal permeability in methotrexate-treated rats
Kazuma Hamada et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Enhancing the Delivery of Anti Retroviral Drug “Saquinavir” Across the Blood Brain Barrier Using Nanoparticles
Supriya D. Mahajan et al.
CURRENT HIV RESEARCH (2010)
C5a alters blood-brain barrier integrity in experimental lupus
Alexander Jacob et al.
FASEB JOURNAL (2010)
The C5a Receptor (C5aR) C5L2 Is a Modulator of C5aR-mediated Signal Transduction
Claire E. Bamberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Inhibition of C5a receptor alleviates experimental CNS lupus
Alexander Jacob et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
C3aR inhibition reduces neurodegeneration in experimental lupus
A. Jacob et al.
LUPUS (2010)
Neurologic Manifestations of Systemic Lupus Erythematosus in Children and Adults
Eyal Muscal et al.
NEUROLOGIC CLINICS (2010)
Endothelial histamine H1 receptor signaling reduces blood-brain barrier permeability and susceptibility to autoimmune encephalomyelitis
Changming Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms
Thomas W. Faust et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Zonula Occludens-1 and-2 Are Cytosolic Scaffolds That Regulate the Assembly of Cellular Junctions
Alan S. Fanning et al.
MOLECULAR STRUCTURE AND FUNCTION OF THE TIGHT JUNCTION: FROM BASIC MECHANISMS TO CLINICAL MANIFESTATIONS (2009)
Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer's Disease
Maria I. Fonseca et al.
JOURNAL OF IMMUNOLOGY (2009)
ZO-1 Stabilizes the Tight Junction Solute Barrier through Coupling to the Perijunctional Cytoskeleton
Christina M. Van Itallie et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
The role of the anaphylatoxins in health and disease
Andreas Klos et al.
MOLECULAR IMMUNOLOGY (2009)
Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis
Michael A. Flierl et al.
CRITICAL CARE (2009)
Transcriptional control of the inflammatory response
Ruslan Medzhitov et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse
Supriya D. Mahajan et al.
BRAIN RESEARCH (2008)
Tight junction regulation by morphine and HIV-1 tat modulates blood-brain barrier permeability
Supriya D. Mahajan et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2008)
The physiology of leukocyte recruitment: An in vivo perspective
Bjoern Petri et al.
JOURNAL OF IMMUNOLOGY (2008)
Differential roles of ICAM-1 and VCAM-1 in leukocyte-endothelial cell interactions in skin and brain of MRL/faslpr mice
M. Ursula Norman et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
New regulators of NF-κB in inflammation
Sankar Ghosh et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Evolving functions of endothelial cells in inflammation
Jordan S. Pober et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Absence of functional alternative complement pathway alleviates lupus cerebritis
Jessy J. Alexander et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Getting to the site of inflammation: the leukocyte adhesion cascade updated
Klaus Ley et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration
Trent M. Woodruff et al.
FASEB JOURNAL (2006)
The role of blood-brain barrier studies in the pharmaceutical industry
A Reichel
CURRENT DRUG METABOLISM (2006)
Complement-dependent apoptosis and inflammatory gene changes in murine lupus cerebritis
JJ Alexander et al.
JOURNAL OF IMMUNOLOGY (2005)
Mitogen-activated protein kinases in apoptosis regulation
T Wada et al.
ONCOGENE (2004)
Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus
V Arora et al.
MOLECULAR IMMUNOLOGY (2004)
Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis
JJ Alexander et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2003)
Increased ICAM-1 and VCAM-1 expression in the brains of autoimmune mice
A Zameer et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Two different transduction pathways are activated by C3a and C5a anaphylatoxins on astrocytes
S Sayah et al.
MOLECULAR BRAIN RESEARCH (2003)
The blood-brain barrier in systemic lupus erythematosus
NJ Abbott et al.
LUPUS (2003)
Complement in central nervous system inflammation
SR Barnum
IMMUNOLOGIC RESEARCH (2002)
Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier
M Gumbleton et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
A signaling pathway from the α5β1 and αvβ3 integrins that elevates bcl-2 transcription
ML Matter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Rad regulates interleukin 1-induced nuclear factor κB activation in an inhibitory protein κBα-independent manner by enhancing the ability of the p65 subunit to transactivate gene expression
CA Jefferies et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system
PJH Jongen et al.
ACTA NEUROLOGICA SCANDINAVICA (2000)
分享论文
